by Truveta Staff | Sep 30, 2022 | News
Next in our Health System Spotlight series, we spoke to Karina Davidson, who leads the Institute of Health System Science and Quantitative Intelligence within The Feinstein Institutes for Medical Research. Davidson is also the Senior Vice President of Research and...
by Terry Myerson, CEO | Sep 27, 2022 | News
One of the biggest challenges the healthcare industry faces today is getting fast answers to pressing medical questions on any disease, drug, or device. To address this critical need, Truveta is a collective of 24 health systems who came together with a...
by Truveta Research | Sep 27, 2022 | Research, Research Insights
Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
by Truveta Staff | Sep 22, 2022 | Culture
It’s Truveta’s second anniversary! We’re so proud of everything our team and health system members have accomplished in the last two years. To honor the occasion, our illustrious Social Media Director, Mary Beth King, whipped up our special shade of Truveta teal to...
by Truveta Research | Sep 22, 2022 | Research, Research Insights
Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
